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a b s t r a c t
Vitronectin (VN) is a multi-functional protein involved in extracellular matrix (ECM)-cell binding
through integrin receptors on the cell surface, which is an important environmental process for main-
taining biological homeostasis. We investigated how VN affects the survival of endothelial cells after
radiation damage. VN attenuated radiation-induced expression of p21, an inhibitor of cell cycle progres-
sion, and selectively inhibited Erk- and p38 MAPK-dependent p21 induction after radiation exposure
through regulation of the activity of GSK-3β. VN also reduced the cleavage of caspase-3, thereby inhibit-
ing radiation-induced apoptotic cell death. These results suggest that VN has important roles in cell
survival after radiation damage.
c© 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
After accidental exposure to a high dose of ionizing radiation (IR),
therapeutic strategies for patients with acute radiation syndrome
(ARS) remain a major problem. At relatively high doses, gastroin-
testinal and vascular syndromes emerge in a dose-dependent man-
ner, which lead to multi-organ dysfunction [1]. Moreover, damage to
the target organ is related to systemic inﬂammatory response mainly
caused by the release of cytokines fromdamaged vascular endothelial
cells [1]. Vascular endothelial cells restrict the passage of inﬂamma-
tory cells and circulating molecules into underling tissues. Following
endothelial cell death after radiation exposure, para-cellular perme-
ability is increased, which leads to unrestricted passage of circulat-
ing molecules and inﬂammatory cells and eventually triggers uncon-
trollable inﬂammation and further tissue damage [2]. Therefore, it is
important to improve survival and to maintain the function of IR-
damaged vascular endothelial cells in order to control and mitigate
ARS.
A recent report showed that IR enhanced the expressionof integrin
αvβ3 in human umbilical vein endothelial cells (HUVECs), and HU-
VECs were sensitized to IR by blocking this receptor [3]. Vitronectin
(VN) recognizes the integrin αvβ3 receptor on the cell surface, result-
ing in receptor clustering for the subsequent initiation of intracellular
signaling pathways [4,5]. Therefore, it is reasonable to postulate that
vascular endothelial cells demand binding of VN by its integrin re-
ceptor in order to sustain its own survival signaling after radiation* Corresponding author. Tel.: +81 432 06 3117; fax: +81 432 84 4095.
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VN is a cell-adhesive glycoprotein found in the extracellularmatrix
(ECM) of various tissues and in circulating blood, and VN is implicated
in various pathophysiological processes including inﬂammation, cell
migration, angiogenesis, and regulation of plasminogen activation
[4]. More than 95% VN in plasma exists as a latent form (monomeric/
dimeric form) and others in the ECM as multimeric forms [4]. The
function and activity of VN strongly depend on its binding partners,
such as plasminogen activator inhibitor 1 (PAI-1), heparin, or cell
surface receptors including integrin receptors [4]. However, it re-
mains unclear how abundant latent VN (concentration: 200–400 μg/
mL) in plasma impacts on the fate of vascular endothelial cells after
IR damage. Therefore, in this study, we investigated the effects and
mechanisms of latent VN in plasma against IR-damaged HUVECs.2. Materials and methods
2.1. Reagents
Human puriﬁed plasma VN protein was purchased from MILLI-
PORE (CC808, Lot NG1888899). Antibodies against GAPDH (#5174),
GSK-3β (#9315), phosphoglycogen-synthase kinase-3β (GSK-3β) at
Ser9 (#9336), p44/42 (extracellular signal-regulated kinase; ERK) ki-
nase (#9102), phospho-ERK at Thr202/Tyr204 (#9101), p38 mito-
gen activated protein kinase (MAPK) (#9212), phospho-p38 MAPK at
Thr180/Tyr182 (#9211), phospho-stress activated protein kinase/c-
Jun-N-terminal kinase (SAPK/JNK) at Thr183/Tyr185 (#9251), AKT
(#9272), AKT1 (#2938), AKT2 (#3063), phospho-AKT at Ser473.V. Open access under CC BY-NC-ND license.
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chased from Cell Signaling Technology. An antibody against SAPK/
JNK (sc-571) was purchased from Santa Cruz Technology, an anti-
body against p21 (556431)was purchased fromBDBioscience, and an
antibody against integrin αv/CD51 was purchased from EPITOMICS.
Inhibitors of PI3K (LY294002),MEK1 (PD98059), p38 (SB203580), and
JNK (JNK inhibitor II, Anthra[1,9-cd]pyrazol-6(2H)-one) were pur-
chased from CALBIOCHEM. An inhibitor of GSK3-β (LiCl) was pur-
chased fromWako.2.2. Cell lines
HUVECs were purchased from the Health Science Research Re-
source Bank andmaintained inMCDB107 (COSUMOBIOCo., Ltd.) sup-
plemented with 15% heat-inactivated FBS, penicillin/streptomycin
(Invitrogen), 10 ng/mL bFGF (Sigma), and 50 μg/mL heparin. Cells
were incubated in a humidiﬁed atmosphere at 37 ◦C with 5% CO2.
Col-I coated dishes (11-018-002, IWAKI) were used for cell culture.2.3. γ -Ray irradiation
Cells were irradiated using a Cesium-137 (Cs137) gammator
(model M Gammator, Irradiation Machinery), at a dose rate of 8.0
Gy/min on a rotating platform.
2.4. Cell cycle analysis
Cells were irradiated and cultured with or without VN (10 μg/mL)
for 28 h. The harvested cells were treated with PBS containing 0.1%
Triton X-100 (Wako) for 5 min on ice, and stained with propidium
iodide (PI; 50 μg/mL, Sigma). An analysis of the cell cycle distribution
was performed using a ﬂuorescent cell analyzer (FACSCalibur, Becton
Dickinson).
2.5. SDS–PAGE and western blotting analysis
Harvested cellswere lysed in SDS sample buffer (300mMTris–HCl,
pH 6.8, 10% SDS, 1% 2-mercaptoethanol, 1% glycerol) with sonication,
and then heated for 7 min at 95 ◦C. Proteins were separated by SDS–
PAGE and transferred onto PVDF membranes (Advantec Toyo). The
membrane was reacted with each primary antibody in Tris-buffered
saline (10 mM Tris–HCl, pH 7.4, 100 mM NaCl, 0.1% Tween-20) sup-
plemented with 2% blocking agent (GE Healthcare) for 1 h at room
temperature after blocking of the membrane. After the primary an-
tibody reaction, membranes were labeled with each corresponding
HRP-conjugated antibody (GE Healthcare) and then detected using
ECL Prime western blotting substrate (GE Healthcare).
2.6. MAPK, AKT and GSK-3β inhibition assay
HUVECs with incubated with inhibitors; LY294002 (20 μM),
PD98059 (50 μM), SB203580 (20 μM), JNK II (200 nM) and/or LiCl
(20 mM), for 2 h at 37 ◦C before irradiation. Then, the cells were ir-
radiated (8 Gy), and cultured for a further 28 h. Harvested cells were
subjected to SDS–PAGE and immunoblotting analysis in accordance
with the procedure described above.
2.7. Statistical analysis
The signiﬁcance of differences between the control and experi-
mental groups was determined using Student’s t-test depending on
the data distribution. Statistical analysis was performed using Excel
2003 software (Microsoft) with add-in software Statcel 2.3. Results
3.1. Exogenously added latent vitronectin prevents γ -ray-induced cell
death in HUVECs
Radiation-enhanced expression of integrinαvwas detected inHU-
VECs by western blotting analysis (Fig. 1(A)), suggesting that cellular
signaling from integrin affects the survival of radiation-damaged cells.
Therefore, we examined whether VN, one of the ligands of integrin
αvβ3, affects the survival of radiation-damaged HUVECs. As shown
in Fig. 1(B), exogenously added latent VN increased the survival ratio
of radiation-damaged HUVECs in a dose-dependent manner, which
was also observed by recombinant VN treatments (Supplementary
Fig. S2(A)). The addition of VN to HUVECs 10 min after irradiation in-
hibited the production of cleaved active-caspase3 and also inhibited
the cleavage of a downstream substrate of caspase3, PARP (Fig. 1(C)).
These results indicated that latent VN can prevent radiation-induced
apoptotic cell death in HUVECs.
3.2. Vitronectin suppresses cell cycle arrest by inhibiting
γ -ray-induced up-regulation of cell cycle inhibitor p21 in HUVECs
In general, radiation induces DNA damage and subsequent cell
cycle arrest before activation of apoptotic cell death. Therefore, we
next examined the effect of VN on cell cycle distribution of irradiated
HUVECs by ﬂow cytometric analysis. As shown in Fig. 2(A), radiation
exposure induced cell cycle arrest at G1 and G2/M phase. However,
VN treatment abolished G1 phase arrest, which was supported by a
1.3-fold increase in the G2/M population compared with radiation
treatment alone (Fig. 2(A)). VN treatment also decreased the sub-G1
phase population by one-third, an indicator of apoptotic DNA frag-
mentation (Fig. 2(A)). These results again support the conclusion that
VN treatment prevents radiation-induced apoptotic cell death in HU-
VECs. Because p21 is an inhibitor of the G1-S phase transition and
its expression is induced by DNA damage, we determined whether
VN affects DNA damage-induced p21 expression. As shown in Fig.
2(B), VN treatment decreased radiation-induced expression of p21
protein. Similarly, recombinant VN also suppressed p21 expression
(Supplementary Fig. S2(B) and (C)). Although the levels of p53, a ma-
jor transactivator of p21, also increased in response to DNA damage,
p53protein levelswereunchangedbyVNtreatment (datanot shown).
These results suggest that other mechanisms may accommodate the
regulation of p21 expression by VN treatment (Fig. 2(B)).
3.3. Vitronectin suppresses γ -ray-induced up-regulation of p21
through prevention of activation of ERK and p38 MAP kinase pathways
in HUVECs
A number of reports indicate that signal transduction, such as
the MAPK pathways, is involved in the regulation of p21 expression,
although the involvement and effect of p21 expression depend on
each cell type [6]. Therefore, we examined the involvement of the
PI3K/AKT, ERK, p38 MAPK, and SAPK/JNK pathways in the radiation-
induced p21 expression in HUVECs. For this purpose, we used chemi-
cal inhibitors, LY294002 for PI3K/AKT, PD98059 for ERK, SB203580 for
p38MAPK, and JNK inhibitor II for SAPK/JNK pathways. Except for the
JNK inhibitor II, the other inhibitors, including LY294002, PD98059,
and SB203580, prevented the radiation-induced expression of p21
in HUVECs (Fig. 3(A)). When pairs of inhibitors, including LY294002,
PD98059, and SB203580, were added, the inhibitory effect was en-
hanced. Furthermore, treatmentwith all three inhibitors inhibited the
expression of p21 much more strongly. Therefore, these results sug-
gest the involvement of the PI3K/AKT, ERK, and p38 MAPK pathways
in the radiation-induced p21 expression inHUVECs.We subsequently
examined whether VN treatment affected the radiation-induced ac-
tivation of the protein kinases in these signal transduction pathways.
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Fig. 1. VN protects against ionizing irradiation-induced cell death in HUVECs. (A)
Radiation-induced integrin αv expression. Cells were cultured for 28 h after 8 Gy irra-
diation. Subsequently, cells in each condition were harvested and whole-cell extracts
were subjected to immunoblotting analysis with the indicated antibodies. C, unirradi-
ated control. (B) Cells were exposed to irradiation at a dose of 8 Gy. VN was added to
the cell culture 10 min after irradiation, and the cells were continued to be cultured
for 28 h. Subsequently, the cells in each condition were harvested, and the number of
viable cells was determined by the trypan blue exclusion test using a hemocytometer.
*p < 0.05 by Student’s t-test. (C) After irradiation, cells were treated with VN, and sub-
sequently harvested as in (B). Whole-cell extracts were subjected to immunoblotting
analysis with the indicated antibodies.
Fig. 2. VN attenuates radiation-induced G1 phase cell cycle arrest through decreasing
the expression level of the cell cycle inhibitor protein p21. Cells were exposed to irra-
diation at a dose of 8 Gy. VN was added to the cell culture 10 min after irradiation, and
cells culturing was continued for 28 h. (A) Cells in each condition were subjected to
cell cycle analysis using PI staining in accordance with the procedure as described in
Section 2. (B)Whole-cell extractswere prepared fromHUVECsunder the indicated con-
ditions and were subjected to immunoblotting analysis with the indicated antibodies.
The relative amounts of p21 protein were quantiﬁed and shown as graphs.
Fig. 3. VN inhibits p21 expression through the ERK and p38MAPK pathways. (A) HU-
VECs were pre-treated with the indicated inhibitors for 2 h before irradiation, and cell
culture was continued for 28 h in the presence of the indicated inhibitors, as shown
in Section 2. Whole-cell extracts were subjected to immunoblotting analysis with the
indicated antibodies. (B, C) Cells were exposed to irradiation at a dose of 8 Gy. VN
was added to the cell culture 10 min after irradiation, and the cell culture was contin-
ued for 28 h. Whole-cell extracts were subjected to immunoblotting analysis with the
indicated antibodies.
VN treatment preferentially inhibited radiation-induced phosphory-
lation of ERK and p38MAPKwhereas phosphorylation of AKT and JNK
was maintained after VN treatment (Fig. 3(B)). Moreover, although
previous studies suggest that AKT1 and AKT2 have distinct functions
in DNA damage response [7], VN treatment did not change the cellu-
lar amount of AKT1 or AKT2 (Fig. 3(C)). Therefore, the above results
indicate that VN treatment prevents radiation-induced p21 expres-
sion through inhibiting the activation of both ERK and p38 MAPK
pathways in HUVECs.
3.4. Vitronectin suppresses γ -ray-induced inactivation of GSK-3β in
HUVECs
Several studies indicate that GSK-3β is involved in the regulation
of p21 expression in response to genotoxic stresses. Therefore, we
initially examined the effect of VN treatment on the phosphorylation
state of GSK-3β at Ser9, an indicator of its inactive form. Consis-
tent with the previous study [8], radiation exposure increased the
phosphorylation of GSK-3β at Ser9 in HUVECs (Fig. 4(A)). VN treat-
ment suppressed the radiation-induced phosphorylation of GSK-3β
at Ser9, which was correlated with a reduction in p21 protein levels.
Because our initial results indicated the involvement of PI3K/AKT,
ERK, and p38MAPKpathways in radiation-induced expression of p21,
we examined the relationship between these protein kinases and
the radiation-induced phosphorylation of GSK-3β. Treatment with
PD98059 or SB203580, but not LY294002, markedly abolished the
phosphorylation of GSK-3β (Fig. 4(B)). On the other hand, when cells
were pre-treated with LiCl, an inhibitor of GSK3β, before irradiation,
phosphorylation of GSK-3β at Ser9 was further increased compared
with cells without the inhibitor (Fig. 4(C)). Moreover, the expression
levels of p21 were also increased (Fig. 4(C)). Collectively, our results
suggest that VN treatment inhibits radiation-induced expression of
p21 through regulation of the activity of GSK-3β in HUVECs.
Masaharu Hazawa et al. / FEBS Open Bio 2 (2012) 334–338 337
Fig. 4. VN inhibits p21 expression thorough the inactivation of GSK-3β following the
ERK and p38MAPK pathways. (A) Cells were exposed to irradiation at a dose of 8 Gy. VN
was added to the cell culture 10 min after irradiation, and cell culture was continued
for 28 h. Whole-cell extracts were subjected to immunoblotting analysis with the
indicated antibodies. (B, C) HUVECs were pre-treated with the indicated inhibitors
for 2 h before irradiation, and cell culture was continued for 28 h in the presence of
the indicated inhibitors, as shown in Section 2. Whole-cell extracts were subjected to
immunoblotting analysis with the indicated antibodies.
4. Discussion
In this study, we demonstrated that latent VN inhibits radiation-
induced p21 expression and protects against apoptotic cell death in
HUVECs via the suppression of ERK and p38 MAPK signal pathways.
Furthermore, VN protected against radiation-induced phosphoryla-
tion of GSK-3β, and inhibition of ERK or p38 MAPK using chemical
inhibitors similarly abolished the radiation-induced phosphorylation
of GSK-3β. Therefore, our results strongly suggest that the reduced
activation of both ERK and p38 MAPK prevented radiation-induced
phosphorylation of GSK-3β in HUVECs. To our best knowledge, this is
the ﬁrst report demonstrating that latent VN improved the survival
of vascular endothelial cells by inhibiting radiation-induced apoptotic
cell death.
We demonstrated that latent VN reduced p21 expression through
the prevention of phosphorylation of GSK-3β in radiation-damaged
HUVECs. This observation is strongly supported by Tan et al. [8]. They
revealed that increased levels of the dephosphorylated form of GSK-
3β at Ser9 might reduce the expression levels of p21 by inhibiting a
transactivator of p21, c-Jun, or by inducing the proteasomal degrada-
tion of p21 [8].
In studying the intracellular signaling pathway of VN, both ERK
and p38 MAPK participated in the anti-apoptotic process in our HU-
VEC model. A recent report also showed that VN inhibits neutrophil
apoptosis [9]. In this report, the anti-apoptotic effect against neu-
trophil apoptosis was regulated through the PI3K/AKT and ERK path-
ways but not the p38MAPK pathway. Thus, the intracellular signaling
of the anti-apoptotic ability of VN may depend on each cell-type or
apoptotic inducer.
VN can exist in two forms with latent (monomer/dimer) or multi-
mers status [4]. Previous studies revealed that ﬁxed multimetric VN
had anti-apoptotic ability against genotoxic stimuli [10,11]. We used
latent VN in our experiment because more than 95% of VN in plasma
is in the latent form [4]. We assumed that an experiment using latent
VNmay be more suitable for examining and reﬂecting anti-apoptotic
ability of VN in vivo against IR-damaged endothelium.However, there
have been no previous reports evaluating the anti-apoptotic activity
of latent VN.
The major biological functions and characteristics of VN may be
determined by the binding ligands and biochemical modiﬁcations
to the protein itself [4]. The integrin receptor is one of the ligands
of VN and is important to the induction of survival signaling after IR
damage [3,4].We revealed that the expression levels of this VN ligand,
integrin αv, were enhanced in IR-damaged HUVECs. Although we did
not examine other VN ligands, e.g. PAI-1, a previous report revealed
that PAI-1 levels were also increased after IR-damage [12], which
was considered interfere with VN-integrin binding [13]. Therefore, it
is possible that quantitative changes in VN ligands could affect the
biological functions of VN in ARS.
With regard to the biochemical modiﬁcations of VN itself, the
phosphorylation of VN at Ser378 by cAMP-dependent protein kinase
A (PKA) leads to reduced PAI-1 binding, whereas phosphorylation
of VN at Ser362 by protein kinase C (PKC) induces persistent PAI-1
binding [14].Moreover, thephosphorylationofVNat Thr50 andThr57
by casein kinase 2 (CK2) leads to enhanced integrin αvβ3 binding
[14]. IR-damaged cells may release various enzymes, including PKA,
PKC or CK2, which could modify biochemical characteristics of VN.
Thus, owing to its multifaceted abilities, the regulatory systems of VN
may be very complicated in vivo. In our limited in vitro study, the
latent form of VN can protect against apoptotic cell death in HUVECs
after IR-damage. However, it is important to also understand these
complicated situations in vivo, and to clarify the precise mechanisms
about how to modify VN.
In conclusion, we revealed that latent VN can attenuate cell cycle
arrest and prevent cell death after IR-damage. Although most plasma
VN exists as a latent form, even this form clearly has the potential to
sustain survival signaling depending on the demands of surrounding
vascular endothelial cells after radiation damage.
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